ONC206 Powder
PNOC023
Phase 1 small_molecule active
Quick answer
ONC206 Powder for Diffuse Midline Glioma (DMG), and Other Recurrent Primary Malignant Central Nervous System (CNS) Tumors is a Phase 1 program (small_molecule) at AXIM BIOTECHNOLOGIES, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AXIM BIOTECHNOLOGIES, INC.
- Indication
- Diffuse Midline Glioma (DMG), and Other Recurrent Primary Malignant Central Nervous System (CNS) Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active